Ketamine and Psychedelic Therapy Near You in St. Louis, MO

How to Find Ketamine Care and a Psychedelic Therapist in St. Louis

There are two practical ways to get ketamine treatment near you in St. Louis. The first is an in-clinic provider: several ketamine therapy providers in the metro offer IV infusions or intramuscular (IM) injections, with clinics in the central corridor around Clayton, in West County, and in south county. The second is at-home care. With Mindbloom, a licensed clinician evaluates you online and, if ketamine therapy is a good fit, prescribes a guided program you complete from home. That online route is how many people get ketamine without booking a clinic chair.

If you are searching for a psychedelic therapist or psychedelic-assisted therapists near you, it helps to know what that phrase can and cannot mean in Missouri today. There is no licensed psilocybin or MDMA program in St. Louis, so where you can actually get psychedelic-assisted therapy right now is through ketamine, the one psychedelic-class medicine a clinician can legally prescribe. Mindbloom offers doctor-led, at-home ketamine therapy for eligible adults across St. Louis and all of Missouri, which is the accessible way to begin psychedelic-style treatment while the other options remain unavailable.

Ketamine and Psychedelic Therapy Across the St. Louis Area

Because Mindbloom works through telehealth, at-home ketamine therapy reaches the entire St. Louis metro the same way, not only the clinic clusters in Clayton or West County. That includes St. Charles, O'Fallon, Chesterfield, Florissant, Kirkwood, Ballwin, Wentzville, and University City, along with the city of St. Louis and the St. Louis County neighborhoods in between. St. Louis is a bi-state region, and its in-clinic market draws patients from across eastern Missouri. Wherever you live in the metro, eligibility begins with the same online clinician evaluation, and approved programs are completed from home.

Your Ketamine and Psychedelic Therapy Options in St. Louis

St. Louis residents have a few real options, and they differ mostly in where treatment happens and what it costs. Here is how the main paths compare:

For many people the deciding factors are convenience and cost. In-clinic IV ketamine and IM ketamine mean traveling to a clinic and paying per session out of pocket, since ketamine therapy is off-label and generally not billed to insurance. Named local examples include Midwest Institute for Hearts and Minds in south county and InVita Health and Wellness for IV infusions, and Clayton Behavioral for IM ketamine, with other providers across the metro. Spravato is offered at certified clinics in the region, including the treatment-resistant depression program at Washington University in St. Louis. At-home ketamine therapy with Mindbloom covers the same medical need through telehealth, with both sublingual and subcutaneous options, guided sessions, and integration support, for eligible adults once a clinician confirms it is a good fit.

Conditions Ketamine Therapy Can Address

Depression is the condition Mindbloom focuses on most, and ketamine treatment for depression is the most common reason people in St. Louis look for this care, whether at a clinic or from home. Beyond depression, ketamine therapy is used for anxiety and for PTSD, where Mindbloom has peer-reviewed outcomes, as well as for grief, burnout, and sleep difficulties. If you are seeking psychedelic treatment for PTSD in particular, ketamine is the psychedelic-class option available now, because MDMA-assisted therapy is not FDA-approved or available. A clinician decides which conditions are appropriate for you during the evaluation, and Mindbloom does not treat conditions its research does not support.

Mindbloom's Psychedelic Therapy Programs and Outcomes

Mindbloom has delivered more than 800,000 guided at-home sessions, making it one of the largest at-home psychedelic-therapy providers. Its outcomes are published, not estimated. The table below comes from Mindbloom's peer-reviewed subcutaneous study, which measured depression, anxiety, and PTSD together. Mindbloom also has two earlier peer-reviewed studies of its sublingual protocol, plus research preprints extending the evidence to grief, burnout, and sleep. It is the largest published evidence base in at-home ketamine therapy, and Mindbloom is the only at-home ketamine provider with peer-reviewed PTSD outcomes.

_{¹ Subcutaneous, six-session course (Parks 2026). Response = ≥50% reduction (PHQ-9/GAD-7) or ≥10-pt (PCL-5); remission = final PHQ-9/GAD-7 <5, or ≥10-pt reduction and PCL-5 <33. ² Grief, PGD-13, n=503. ³ Burnout, MBI-GS, n=395. ⁴ Sleep, PHQ-9 Item 3, n=13,963; single-item measure, and ketamine is off-label for sleep. ᵃ Grief remission = no longer met diagnostic criteria (71.1% DSM-5-TR). ᵇ Burnout response = improved on ≥1 dimension (69.6%); remission = fell below the burnout threshold (59.5%). ᶜ Sleep remission = complete resolution (score 0). Individual results vary.}

Mindbloom offers tailored psychedelic-therapy programs, built with mental-health thought leaders, that use the psychedelic modality to address specific outcomes rather than only prescribing medication for them. Programs include Grief, Habit Change, Anxiety, Depression, Self-Love, and Burnout.

How these outcomes compare to established treatments, each comparison drawn from a specific study:

• Mindbloom's reported depression response rate is roughly 38% higher than the rate reported in a study of psychotherapy for depression (56.6% vs about 41%), and reached faster.¹ ⁵
• Mindbloom's reported at-home PTSD response rate exceeds the rate reported in the leading repeated-infusion IV ketamine trial (76.7% vs 67%).¹ ⁶
• Mindbloom's reported grief outcomes are as high as those reported in studies of the gold-standard grief therapy, in about a third of the time (76% response, within its 66 to 82% range, reached in about 6 sessions versus 16).² ⁷
• Mindbloom's reported depression response (56.6%) is at or above the rate reported in the largest controlled trials of single-dose psilocybin for depression (about 37 to 42%), on a far larger published evidence base and delivered at home rather than in a full-day, in-person licensed-center session.¹ ⁸

Is Ketamine Legal in Missouri? Is Psilocybin?

Ketamine is legal in Missouri. It is an FDA-approved medication in Schedule III, and licensed clinicians can prescribe it for mental health conditions, including through telehealth, so eligible adults in St. Louis can begin now, in a clinic or from home. The honest answer to "is ketamine legal in Missouri" is yes.

Psilocybin is a different story. It remains a Schedule I controlled substance in Missouri, and possession is a felony. St. Louis has decriminalized only marijuana, not psilocybin, and no Missouri city has decriminalized entheogens.¹² ¹³ MDMA-assisted therapy is not FDA-approved or available anywhere, and LSD and ayahuasca are not legal therapy options either. A 2026 federal executive order on psychedelics did not change Missouri law. That is the practical reason ketamine matters here: it is the psychedelic-class therapy St. Louis residents can legally start today, while the others remain unavailable. If Missouri law changes, the picture may change with it, but this is where things stand now.

How At-Home Ketamine Therapy Works and What to Expect

Mindbloom begins with an online evaluation by a licensed Missouri clinician, who reviews your history and decides whether ketamine therapy is appropriate. This is a genuine medical gate, not a formality: treatment is for eligible adults, and a clinician confirms it is a good fit before anything is prescribed. If approved, your medicine and a guided program are shipped to you, and you complete sessions at home with preparation and integration support and a peer treatment monitor present.

During a session, ketamine brings a temporary shift in perception that most people find gentle in a calm home setting. Common short-lived effects such as mild dissociation, changes in perception, and nausea ease as the session ends. Treatment frequency is personalized and clinician-guided rather than a fixed schedule, and many people feel early relief with benefits that build over a full course. Mindbloom is also designed to work alongside existing care, so if you already see a therapist or psychiatrist in the St. Louis area, your at-home program can complement that relationship.

Cost, Insurance, and Who Is a Candidate

At-home ketamine therapy with Mindbloom costs $165 to $215 per session depending on the program length you choose, with HSA and FSA funds accepted and possible out-of-network reimbursement. Because ketamine therapy is off-label, it is generally not covered directly by insurance, at home or in a clinic. In-clinic IV and IM ketamine in St. Louis are billed as a series and typically run about $300 to $600 or more per session, with a six-session induction course around $2,100 to $3,000.¹¹ Spravato is the one modality where insurance coverage is possible, but only if you qualify and the insurer approves it in advance; otherwise it is out of pocket.

Candidacy is a clinical decision. Ketamine therapy is generally considered for adults with depression, anxiety, PTSD, and related conditions, often when other treatments have not done enough, and it is not right for everyone. Missouri also carries a real access gap that makes an at-home option matter: the state has about 289.8 mental-health providers per 100,000 people, below the national average, and its suicide rate of 18.4 per 100,000 runs above the national 14.7, with the strain heaviest in rural areas outside the St. Louis metro.⁹ ¹⁰ The online evaluation exists to sort out whether treatment fits you, so the honest way to find out is to complete that assessment.